Le Lézard
Classified in: Science and technology, Business
Subject: OTC

Vapor Group, Inc., VPOR, Revenues for July, August and September Jump to Over $500,000, 10 Times 2nd Quarter Results


MIAMI, November 14, 2017 /PRNewswire/ --

Vapor Group, Inc. (OTC Pink: VPOR), ("Company"), reported today that revenues for the three months ended September 30th were over $500,000, which is 10 times the 2nd quarter revenues. Management credits the sales surge to the growing worldwide distribution and sales success of Easy Grindertm.

Yaniv Nahon President of the Company, said, "Easy Grindertm sales continue to climb both domestically and internationally. During the third quarter we added major new U.S distribution giving us thousands of points-of-sale for Easy Grindertm. Today this momentum has accelerated with the addition of new overseas distribution." He added, "We believe this sales momentum will continue to build from the increasing worldwide market awareness of Easy Grindertm which is being achieved by the efforts of our distributors as well as through our own ongoing marketing campaigns. Year-end revenues will definitely further demonstrate this continued sales success."

About Vapor Group, Inc.
Vapor Group, http://www.vaporgroup.com is focused on the acquisition and development of commercially viable intellectual property and proprietary products.

The Company's subsidiary, Total Vapor, Inc. is the worldwide distributor of the revolutionary, hand-held automatic Easy Grindertm. For more information or to place an order, visit http://www.easygrinder.com visit Amazon.com at   http://a.co/5HOPUkE , email [email protected] or you can call us at 844-420-EASY (3279).  Easy Grindertm is shippable to Canada.

Vapor Group also owns Simple Cork, Inc., http://www.simplecork.com the developer of a new, multi-nationally patented combination wine bottle cork/opener being prepared for market entry in 2018.

If you have specific questions about the Company, please email us at [email protected].

Safe Harbor Statement:

This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Such statements include any that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "likely", "should", "could", "would", "may" or similar words or expressions. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those in such statements, which involve risks and uncertainties, including those relating to the Company's ability to grow. Actual results may differ materially from those predicted and any reported should not be considered an indication of future performance. Potential risks and uncertainties include the Company's operating history and resources, economic, competitive, and equity market conditions.

CONTACT:
Vapor Group, Inc.
+1-954-883-9525


SOURCE Vapor Group, Inc.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: